AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide
16 registrations across 1 African market— 16 active
Markets with Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Odizat HCT 10/160/25 mg Tablets_ Tablet | 🇳🇬Nigeria | Bezik Pharma Limited | active | Nov 2030 |
| Odizat HCT 10/160/12.5 mg Tablets_ Tablet | 🇳🇬Nigeria | Bezik Pharma Limited | active | Nov 2030 |
| Avsar Plus 160/10/25 mg Tablet Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Oct 2030 |
| Avsar Plus 160/10/12.5 mg Tablet_ Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Aug 2030 |
| Avsar Plus 160/5/25 mg Tablet_ Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Aug 2030 |
| Avsar Plus 320/10/25 mg_ Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Aug 2030 |
| Trivalam H Tablet Tablet | 🇳🇬Nigeria | Expharlab Limited | active | Mar 2029 |
| Amlodipine 5 mg, Valsartan 160 mg, Hydrochlorothiazide 25 mg Tablet (active ingredient spelling) Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Feb 2029 |
| Amlodipine 5 mg, Valsartan 160 mg, Hydrochlorothiazide 12.5 mg Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Feb 2029 |
| Amlodipine 10 mg, Valsartan 160 mg, Hydrochlorothiazide 12.5 mg** Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Jan 2029 |
| Amlodipine 10 mg, Valsartan 160 mg, Hydrochlorothiazide 25 mg** Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Jan 2029 |
| Exforge HCT 10/160/25 mg** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Dec 2028 |
| Exforge HCT 10 mg/320 mg/25 mg Tablet** (duplicate) Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Dec 2025 |
| Exforge HCT 5 mg/160 mg/25 mg Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Nov 2025 |
| Exforge HCT 5 mg/160 mg/12.5 mg Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Nov 2025 |
| Exforge HCT 10 mg/160 mg/12.5 mg Tablets** (duplicate) Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Nov 2025 |
Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide in Africa — Regulatory Overview
Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide is registered across 1 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 16 registrations, 16 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.